Health

Results: 337-348 of 6038

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

PR Newswire associated0

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

PR Newswire associated0

XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

GlobeNewswire associated0

First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient

PR Newswire associated0

Volta Labs Expands Long-Read Sequencing Capabilities with Automated Oxford Nanopore Library Prep App on Callisto™

PR Newswire associated0

LabConnect Selects Deloitte to Streamline Financial and Business Operations

PR Newswire associated0

European Commission Grants Orphan Drug Designation to Florbetaben (18F) for Diagnosis of ATTR Amyloidosis

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies

Chancellor invests in Britain’s renewal with up to 4 million additional NHS tests and procedures over the next five years